Clindamycin for intraincisional antibiotic prophylaxis in dermatologic surgery.

Objective: To assess the efficacy of intraincisional clindamycin therapy as an alternative to nafcillin treatment in decreasing the risk of postoperative wound infections in dermatologic surgery.

Design: Prospective, double-blinded, randomized, placebo-controlled trial conducted over a 7-month period.

Setting: Three private practice Mohs micrographic surgery referral centers.